Personal information

AI, machine learning, biomedical data science, systems biology, synthetic biology
Japan, United States

Activities

Employment (5)

Tokyo Medical and Dental University: Tokyo, JP

2022-02 to present | Professor (Department of AI Systems Medicine)
Employment
Source: Self-asserted source
Hideyuki Shimizu

Harvard Medical School: Boston, MA, US

2021-04 to 2022-01 | Research Fellow (Department of Systems Biology)
Employment
Source: Self-asserted source
Hideyuki Shimizu

Kyushu University: Fukuoka, JP

2020-10 to 2021-03 | Assistant Professor (Institute of bioregulation)
Employment
Source: Self-asserted source
Hideyuki Shimizu

Kyushu University: Fukuoka, JP

2018-04 to 2020-09 | Research Scholar (Institute of bioregulation)
Employment
Source: Self-asserted source
Hideyuki Shimizu

Iwate Chubu Hopital: Kitakami, JP

2012-04 to 2014-03 | Resident doctor
Employment
Source: Self-asserted source
Hideyuki Shimizu

Education and qualifications (2)

Kyushu University: Fukuoka, JP

2014-04 to 2018-03 | Ph.D (medical science)
Education
Source: Self-asserted source
Hideyuki Shimizu

Tohoku University: Sendai, JP

2006-04 to 2012-03 | MD
Education
Source: Self-asserted source
Hideyuki Shimizu

Works (18)

Risk factors and development of machine learning diagnostic models for lateral lymph node metastasis in rectal cancer: multicentre study

BJS Open
2024-07-02 | Journal article
Contributors: Shunsuke Kasai; Akio Shiomi; Hideyuki Shimizu; Monami Aoba; Yusuke Kinugasa; Takuya Miura; Kay Uehara; Jun Watanabe; Kazushige Kawai; Yoichi Ajioka
Source: check_circle
Crossref

Bayesian network enables interpretable and state-of-the-art prediction of immunotherapy responses in cancer patients

PNAS Nexus
2023-05-02 | Journal article
Contributors: Hideki Hozumi; Hideyuki Shimizu; Philip Furmanski
Source: check_circle
Crossref

LIGHTHOUSE illuminates therapeutics for a variety of diseases including COVID-19

iScience
2022-11 | Journal article
Part of ISSN: 2589-0042
Contributors: Hideyuki Shimizu; Manabu Kodama; Masaki Matsumoto; Yasuko Orba; Michihito Sasaki; Akihiko Sato; Hirofumi Sawa; Keiichi Nakayama
Source: Self-asserted source
Hideyuki Shimizu

Bayesian network enables interpretable and state-of-the-art prediction of immunotherapy responses in cancer patients

2022-11-04 | Preprint
Contributors: Hideki Hozumi; Hideyuki Shimizu
Source: check_circle
Crossref

FKBP52 and FKBP51 differentially regulate the stability of estrogen receptor in breast cancer

Proceedings of the National Academy of Sciences
2022-04-12 | Journal article
Part of ISSN: 0027-8424
Part of ISSN: 1091-6490
Contributors: Makoto Habara; Yuki Sato; Takahiro Goshima; Masashi Sakurai; Hiroyuki Imai; Hideyuki Shimizu; Yuta Katayama; Shunsuke Hanaki; masaki takahiro; Masahiro Morimoto et al.
Source: Self-asserted source
Hideyuki Shimizu

Kastor and Polluks polypeptides encoded by a single gene locus cooperatively regulate VDAC and spermatogenesis

Nature Communications
2022-02-28 | Journal article
Part of ISSN: 2041-1723
Contributors: Shintaro Mise; Akinobu Matsumoto; Keisuke Shimada; Toshiaki Hosaka; Masatomo Takahashi; Kazuya Ichihara; Hideyuki Shimizu; Chisa Shiraishi; Daisuke Saito; Mikita Suyama et al.
Source: Self-asserted source
Hideyuki Shimizu

A universal molecular prognostic score for gastrointestinal tumors

npj Genomic Medicine
2021-12 | Journal article
Part of ISSN: 2056-7944
Contributors: Hideyuki Shimizu; Keiichi Nakayama
Source: Self-asserted source
Hideyuki Shimizu

Combinatorial analysis of translation dynamics reveals eIF2 dependence of translation initiation at near-cognate codons

Nucleic Acids Research
2021-07-21 | Journal article
Part of ISSN: 0305-1048
Part of ISSN: 1362-4962
Contributors: Kazuya Ichihara; Akinobu Matsumoto; Hiroshi Nishida; Yuki Kito; Hideyuki Shimizu; Yuichi Shichino; Shintaro Iwasaki; Koshi Imami; Yasushi Ishihama; Keiichi Nakayama
Source: Self-asserted source
Hideyuki Shimizu

A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer

Nature Communications
2020-12 | Journal article
Part of ISSN: 2041-1723
Contributors: Manabu Kodama; Kiyotaka Oshikawa; Hideyuki Shimizu; Susumu Yoshioka; Masatomo Takahashi; Yoshihiro Izumi; Takeshi Bamba; Chisa Tateishi; Takeshi Tomonaga; Masaki Matsumoto et al.
Source: Self-asserted source
Hideyuki Shimizu
grade
Preferred source (of 2)‎

Loss of Fbxw7 Impairs Development of and Induces Heterogeneous Tumor Formation in the Mouse Mammary Gland

Cancer Research
2020-12-15 | Journal article
Part of ISSN: 0008-5472
Part of ISSN: 1538-7445
Contributors: Ichiro Onoyama; Keiichi Nakayama; Hideyuki Shimizu; Keiichi Nakayama
Source: Self-asserted source
Hideyuki Shimizu

Skp2 contributes to cell cycle progression in trophoblast stem cells and to placental development

Genes to Cells
2020-06 | Journal article
Part of ISSN: 1356-9597
Part of ISSN: 1365-2443
Contributors: Yuhei Yamauchi; Akihiro Nita; Masaaki Nishiyama; Yoshiharu Muto; Hideyuki Shimizu; Hirokazu Nakatsumi; Keiichi Nakayama
Source: Self-asserted source
Hideyuki Shimizu

Artificial intelligence in oncology

Cancer Science
2020-05 | Journal article
Part of ISSN: 1347-9032
Part of ISSN: 1349-7006
Contributors: Hideyuki Shimizu; Keiichi Nakayama
Source: Self-asserted source
Hideyuki Shimizu

A fail-safe system to prevent oncogenesis by senescence is targeted by SV40 small T antigen

Oncogene
2020-03-05 | Journal article
Part of ISSN: 0950-9232
Part of ISSN: 1476-5594
Contributors: Kiyotaka Oshikawa; Masaki Matsumoto; Manabu Kodama; Hideyuki Shimizu; Keiichi I. Nakayama
Source: Self-asserted source
Hideyuki Shimizu

A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients

EBioMedicine
2019-08 | Journal article
Part of ISSN: 2352-3964
Contributors: Hideyuki Shimizu; Keiichi Nakayama
Source: Self-asserted source
Hideyuki Shimizu

Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis

Journal of Experimental Medicine
2019-04-01 | Journal article
Part of ISSN: 0022-1007
Part of ISSN: 1540-9538
Contributors: Yoshiharu Muto; Toshiro Moroishi; Kazuya Ichihara; Masaaki Nishiyama; Hideyuki Shimizu; Hidetoshi Eguchi; Kyoji Moriya; Kazuhiko Koike; Koshi Mimori; Masaki Mori et al.
Source: Self-asserted source
Hideyuki Shimizu

Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells

JCI Insight
2019-02-21 | Journal article
Part of ISSN: 2379-3708
Contributors: Hideyuki Shimizu; Shoichiro Takeishi; Hirokazu Nakatsumi; Keiichi I. Nakayama
Source: Self-asserted source
Hideyuki Shimizu

DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells

Biochemical and Biophysical Research Communications
2012-04 | Journal article
Part of ISSN: 0006-291X
Contributors: Yuriko Saiki; Yuki Yoshino; Hiroko Fujimura; Tatsuya Manabe; Yuki Kudo; Miki Shimada; Nariyasu Mano; Tomohiro Nakano; Yoonha Lee; Shinjiro Shimizu et al.
Source: Self-asserted source
Hideyuki Shimizu

Identification of epigenetically silenced genes in human pancreatic cancer by a novel method “microarray coupled with methyl-CpG targeted transcriptional activation” (MeTA-array)

Biochemical and Biophysical Research Communications
2011-07 | Journal article
Part of ISSN: 0006-291X
Contributors: Hideyuki Shimizu; Akira Horii; Makoto Sunamura; Fuyuhiko Motoi; Shinichi Egawa; Michiaki Unno; Shinichi Fukushige
Source: Self-asserted source
Hideyuki Shimizu